Skip to Content

MD Anderson Events

Emil J. Freireich Lymphoma/Myeloma Grand Rounds

Emil J. Freireich Lymphoma/Myeloma Grand Rounds

Emil J Freireich Grand Rounds

Department of Lymphoma/Myeloma

In Collaboration with the

Department of Leukemia and Department of Stem Cell Transplantation

 

Elisabet Manasanch M.D.

Assistant Professor of Medicine

Department of Lymphoma/Myeloma

MD Anderson Cancer Center

 

Presenting

 

“Updates on Myeloma Precursor Disease”

 

September 20, 2017

8:00 a.m. – 9:00 a.m.

 

Pickens Tower, 3rd Floor, Rooms 1, 2, 7 & 8

To add this event to your calendar click this link Lymphoma/Myeloma Hematology Grand Rounds and click “add event to my calendar”: http://inside3.mdanderson.org/apps/calendar/event/Emil_J_Freireich_LymphomaMyeloma_Hematology_Grand_Rounds_31839.html

After attending this activity, the target audience of Physicians from Leukemia, Lymphoma/Myeloma, Stem Cell Transplantation and Research Staff, Nurses, Data Coordinators, Laboratory Staff, Post-Doctoral Fellows, Instructors, and Research Staff in Lab should be able to:

 

  • Assess clinical and translational research in lymphoma and plasma cell dyscrasia (knowledge, competence);
  • Increase collaboration between disciplines regarding lymphoma and plasma cell dyscrasia (knowledge, competence, performance);
  • Update knowledge and collaboration in trials and research (knowledge, competence, performance);
  • Accelerate the speed of translational research and clinical trials to achieve better patient outcomes (knowledge, competence, performance, patient outcomes);

 

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of The University of Texas MD Anderson Cancer Center that the program chair(s), planning committee member, faculty/teacher/ author, or CME activity reviewer must disclose any relevant financial relationships with commercial interests whose products may be discussed in the activities, if any.  MD Anderson also requires that faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products.  Specific disclosure will be made to the participants prior to the educational activity.

 

Vertical_tagMD Anderson complies with the Physician Payments Sunshine Act as part of the Affordable Care Act (ACA).  Accordingly, we may be required to collect information on transfer of value provided to any covered recipient under the ACA.

Date: 9/20/17, 8am to 9am
Time: 9/20/17, 8am to 9am
Location: Pickens Academic Tower, Floor 3, Room 1 (FCT3.4167)
Format: Grand Rounds
CME: 1.0
Facilitator: Loretta Nastoupil
Speaker: Elisabet Manasanch
Contact: Lisa Foucheaux - (713) 745-4247 - lmfoucheaux@mdanderson.org